BIAFW
Income statement / Annual
Last year (2023), bioAffinity Technologies, Inc.'s total revenue was $2.53 M,
an increase of 52,627.44% from the previous year.
In 2023, bioAffinity Technologies, Inc.'s net income was -$7.94 M.
See bioAffinity Technologies, Inc.’s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
Operating Revenue |
$2.53 M
|
$4,803.00
|
$0.00
|
$0.00
|
$0.00
|
Cost of Revenue |
$1.99 M |
$467.00 |
$4,817.00 |
$22,242.00 |
$40,278.00 |
Gross Profit |
$542,023.00 |
$4,336.00 |
-$4,817.00 |
-$22,242.00 |
-$40,278.00 |
Gross Profit Ratio |
0.21 |
0.9 |
0 |
0 |
0 |
Research and Development
Expenses |
$1.72 M
|
$1.29 M
|
$1.33 M
|
$1.61 M
|
$1.85 M
|
General & Administrative
Expenses |
$6.79 M
|
$2.73 M
|
$880,772.00
|
$994,343.00
|
$0.00
|
Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Selling, General &
Administrative Expenses |
$6.79 M
|
$2.73 M
|
$880,772.00
|
$994,343.00
|
$1.20 M
|
Other Expenses |
-$27,796.00 |
-$1.87 M |
$724,928.00 |
-$4.28 M |
$0.00 |
Operating Expenses |
$8.52 M |
$4.02 M |
$2.21 M |
$2.60 M |
$3.05 M |
Cost And Expenses |
$10.51 M |
$4.02 M |
$2.21 M |
$2.60 M |
$3.09 M |
Interest Income |
$122,131.00 |
$46,708.00 |
$424.00 |
$1,073.00 |
$2,777.00 |
Interest Expense |
$37,125.00 |
$2.53 M |
$1.00 M |
$382,171.00 |
$214,834.00 |
Depreciation &
Amortization |
$249,592.00
|
$10,182.00
|
$4,817.00
|
$22,242.00
|
$40,278.00
|
EBITDA |
-$7.72 M
|
-$5.82 M
|
-$1.48 M
|
-$6.86 M
|
-$3.05 M
|
EBITDA Ratio |
-3.05 |
-1211.97 |
0 |
0 |
0 |
Operating Income Ratio
|
-3.15
|
-835.12
|
0
|
0
|
0
|
Total Other
Income/Expenses Net |
$57,212.00
|
-$4.14 M
|
-$4.12 M
|
-$4.66 M
|
-$212,059.00
|
Income Before Tax |
-$7.92 M |
-$8.15 M |
-$6.32 M |
-$7.27 M |
-$3.30 M |
Income Before Tax Ratio
|
-3.13
|
-1697.2
|
0
|
0
|
0
|
Income Tax Expense |
$20,993.00 |
$2,459.00 |
$1,950.00 |
$2,750.00 |
$3,200.00 |
Net Income |
-$7.94 M |
-$8.15 M |
-$6.33 M |
-$7.27 M |
-$3.31 M |
Net Income Ratio |
-3.13 |
-1697.71 |
0 |
0 |
0 |
EPS |
-0.91 |
-1.81 |
-0.86 |
-0.99 |
-0.45 |
EPS Diluted |
-0.91 |
-1.81 |
-0.86 |
-0.99 |
-0.45 |
Weighted Average Shares
Out |
$8.75 M
|
$4.50 M
|
$7.38 M
|
$7.38 M
|
$7.38 M
|
Weighted Average Shares
Out Diluted |
$8.75 M
|
$4.50 M
|
$7.38 M
|
$7.38 M
|
$7.38 M
|
Link |
|
|
|
|
|